ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
US FDA finds zero 483 observations and grants NAI to Centaur Pharmaceutical’s Finished Dosage facility in Pune
June 14, 2019In addition to US FDA accreditation, the said facility also conforms to MHRA (UK), TGA (Australia), Health Canada, MCC (South Africa) and WHO-GMP standards -
Regis Technologies’ 2019 FDA Inspection Yields NAI Classification (Zero 483s)
May 05, 2019Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, earned perfect results from its April 2019 FDA inspection.
Pharma Sources Insight January 2025
